Entecavir Tablet, Film Coated
Product Images NDC 65162-449

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Entecavir (NDC 65162-449). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Entecavir Tablets 1)

FDA Label Image

10 (Entecavir Tablets 2)

This text describes a medication called Entecavir, which comes in tablet form with a strength of 0.5 mg per tablet. It is only available with a prescription and comes in a package of 30 tablets. The medication should be stored in a tightly closed container at a temperature between 20° to 25°C (68" to 77°F) with permissible excursions between 15° to 30°C (59° to 86°F), and protected from light. The package insert provides information on indications and dosage. The medication is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ.*

FDA Label Image

10 (Entecavir Tablets 3)

NDC 65162-449-03 is a medication called Entecavir, which is available in the form of Tablets. Each tablet contains 1 mg of Entecavir. It is recommended to store this medication at a temperature of 20° to 25°C (68" to 77’1 F). However, the temperature can be varied between 15° to 30°C (59 to 86°F) in a tightly closed container. It is important to protect these tablets from light. For more information regarding dosage and indications, refer to the package. The manufacturer of this product is Amneal Pharmaceuticals LLC located in Bridgewater, NJ 08807. This information was revised in December 2017.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.